Does UnitedHealthcare Cover Zepbound? What UnitedHealthcare's 2026 Policies Say

UnitedHealthcare's answer on Zepbound depends on whether your plan chose to cover weight loss drugs. This guide quotes and dates the two UnitedHealthcare pharmacy policies effective September 1, 2026: the optional weight loss program and the separate route limited to obstructive sleep apnea.

Short answer

As of September 2026, UnitedHealthcare's public policies say coverage of Zepbound for weight loss depends on whether the employer or plan sponsor chose to cover weight loss drugs: its prior authorization program, effective September 1, 2026, calls itself "an optional program that is put in place for clients or businesses that have elected to cover weight loss products". A separate UnitedHealthcare policy, effective the same day, says weight loss medications are typically a benefit exclusion and allows coverage of Zepbound for obesity with obstructive sleep apnea when its criteria are met. Coverage depends on your specific plan and its formulary. Majesta Health does not bill insurance.

Majesta Health Editorial TeamReviewed by Majesta team
Published 14 min read

Whether UnitedHealthcare covers Zepbound starts with a choice made before anyone fills a prescription: whether the employer or plan sponsor behind your plan chose to cover weight loss medications. Two UnitedHealthcare pharmacy policies, both effective September 1, 2026, describe what happens on each side of that choice.

This guide reads those two documents. Both are published in the commercial prior authorization section of UnitedHealthcare's provider website, uhcprovider.com, and both were read on September 29, 2026. Quotes are word for word. The page does not predict what any plan will decide, and it does not reprint amounts, schedules or clinical figures.

Coverage depends on your specific plan and its formulary. Majesta Health does not bill insurance.

*What this guide covers:*

  • The two UnitedHealthcare policies and what each one says about Zepbound
  • What "an optional program" means for the plan you are enrolled in
  • The prior authorization criteria for Zepbound for weight loss
  • The separate route limited to obstructive sleep apnea
  • The four states the weight loss program names
  • How long a first approval lasts and what a renewal asks for
  • How to check your own UnitedHealthcare plan

Does UnitedHealthcare cover Zepbound in 2026?

It depends on the plan. UnitedHealthcare's public policies describe two routes, and which one matters turns on whether the plan covers weight loss medications at all.

DocumentWhat it says about ZepboundWho it applies toSource and date
Program Number 2026 P 1114-22, Prior Authorization/Notification, Plans with Weight Loss/Appetite Suppression Medication CoverageZepbound is one of the listed products; the document sets prior authorization criteria for weight loss and for moderate to severe obstructive sleep apnea"clients or businesses that have elected to cover weight loss products with Prior Authorization/Notification"UnitedHealthcare Pharmacy, effective 9/1/2026; read September 29, 2026
Footnote c of the same document"Refer to Nonformulary Zepbound criteria for plans that do not cover weight loss medications."plans that do not cover weight loss medicationsUnitedHealthcare Pharmacy, effective 9/1/2026; read September 29, 2026
Program Number 2026 P 1475-3, Prior Authorization/Non-Formulary, Zepbound (tirzepatide), Obstructive Sleep Apnea Only"The program allows for coverage of Zepbound for obesity with obstructive sleep apnea."requests for obstructive sleep apnea that meet the listed criteriaUnitedHealthcare Pharmacy, effective 9/1/2026, P&T approval dates 3/2025, 12/2025, 6/2026; read September 29, 2026
State sentence in P 1114-22names California, New Mexico, North Dakota Essential Health Benefits (EHB) and New Yorkplans subject to those state requirementsUnitedHealthcare Pharmacy, effective 9/1/2026; read September 29, 2026
Zepbound label, section 1two approved uses: weight reduction and its long-term maintenance, and moderate to severe obstructive sleep apnea in adults with obesitythe two uses both policies are built aroundDailyMed, label updated August 28, 2026; read September 29, 2026

The first document is UnitedHealthcare's prior authorization program for plans that cover weight loss drugs. Its background section opens: "This is an optional program that is put in place for clients or businesses that have elected to cover weight loss products with Prior Authorization/Notification." Zepbound is on its list of products, alongside other weight loss medications.

The second document covers a narrower case. Its background section says: "Medications for the purpose of weight loss are typically a benefit exclusion. The program allows for coverage of Zepbound for obesity with obstructive sleep apnea."

Read together, the two documents give a three-part answer for 2026:

  • If the plan elected weight loss medication coverage, a Zepbound request for weight loss is reviewed against the criteria in P 1114-22.
  • If the plan does not cover weight loss medications, footnote c sends the reader to separate "Nonformulary Zepbound criteria", and UnitedHealthcare publishes a Zepbound document of that type, P 1475-3, limited to obstructive sleep apnea.
  • In both cases, the decision is made on the plan you are enrolled in, not on the insurer's name on the card.

Both documents carry the same footnote: "State mandates may apply. Any federal regulatory requirements and the member specific benefit plan coverage may also impact coverage criteria. Other policies and utilization management programs may apply."

What does "an optional program" mean for your plan?

It means the weight loss program is not switched on for every UnitedHealthcare plan. The document places the choice with "clients or businesses that have elected to cover weight loss products". For a member, the practical question is whether the plan you are enrolled in made that election.

Two plan terms help here. HealthCare.gov defines a formulary as "A list of prescription drugs covered by a prescription drug plan or another insurance plan offering prescription drug benefits. Also called a drug list." It defines prior authorization as "Approval from a health plan that may be required before you get a service or fill a prescription in order for the service or prescription to be covered by your plan."

Put in those terms:

  • A plan that elected weight loss medication coverage can include Zepbound on its drug list, with a prior authorization review against the program's criteria.
  • A plan that did not make that election typically excludes medications used for weight loss. That is the wording of the sleep apnea policy: "Medications for the purpose of weight loss are typically a benefit exclusion."
  • Two people can both carry a UnitedHealthcare card and get different answers, because the difference sits in the plan, not in the insurer.

If your coverage comes through an employer, the employer's benefits office can tell you whether the plan includes weight loss medication coverage. UnitedHealthcare can tell you the same thing from the plan record.

What are UnitedHealthcare's prior authorization criteria for Zepbound for weight loss?

Section 2 of P 1114-22 sets the general criteria for a first approval. A request has to meet all of the following, summarized here with the document's own words in quotes:

  1. The purpose of the request. For weight loss, the document's wording is "Treatment is being requested for appetite suppression or weight loss". The same list has a separate line for Zepbound requested "for moderate to severe obstructive sleep apnea".
  2. Age. The document sets an age requirement for each group of products.
  3. Lifestyle. The medicine is "Used as an adjunct to lifestyle modification (e.g., dietary or caloric restriction, exercise, behavioral support, community-based program)".
  4. Body mass index. A body mass index (BMI) of 30 kg/m2 or higher, or a BMI of 27 kg/m2 or higher together with a weight-related condition. The document's examples of such conditions are "dyslipidemia, hypertension, type 2 diabetes, sleep apnea".

These criteria sit alongside the approved uses in the Zepbound label. Section 1 of the label, updated August 28, 2026, reads: "ZEPBOUND is indicated in combination with a reduced-calorie diet and increased physical activity: to reduce excess body weight and maintain weight reduction long term in adults with obesity or adults with overweight in the presence of at least one weight-related comorbid condition. to treat moderate to severe obstructive sleep apnea (OSA) in adults with obesity." For background on the drug class, see what a GLP-1 medication is.

The document has a separate section for one group of plans, titled "Coverage Criteria for North Dakota Fully Insured EHB (Small Group and Individual) Plans". Its BMI threshold for Zepbound is higher, 40 kg/m2 or more. Under "Additional Clinical Rules", the document also says: "Supply limits may be in place."

The same program lists Wegovy injection among its products, with its own criteria and approval periods. For plans that do not cover weight loss medications, footnote b says: "Refer to Nonformulary Wegovy criteria for plans that do not cover weight loss medications." This page did not review that separate Wegovy document.

Can UnitedHealthcare cover Zepbound for sleep apnea when weight loss drugs are excluded?

UnitedHealthcare's policy P 1475-3 describes that route. Its title limits it to obstructive sleep apnea, and its background section says: "Medications for the purpose of weight loss are typically a benefit exclusion. The program allows for coverage of Zepbound for obesity with obstructive sleep apnea."

For a first approval, the policy lists all of the following, summarized with its own words in quotes:

  • The request is for sleep apnea: "Treatment is being requested for obstructive sleep apnea".
  • Age: "Patient is 18 years of age or older".
  • Medical records showing a BMI of 30 kg/m2 or higher.
  • Moderate to severe obstructive sleep apnea shown by "a sleep study" and by one of three sleep study measures above the threshold the policy sets, for example an apnea-hypopnea index (AHI) above 15 events per hour.
  • "At least one previous unsuccessful dietary effort to lose weight".
  • Either continued symptoms of sleep apnea despite adherence to positive airway pressure (PAP) therapy, as the policy defines adherence, or "Patient is not a candidate for PAP therapy".
  • Use "in combination with a reduced calorie diet and increased physical activity".
  • No diagnosis of diabetes, including a lab threshold the policy states.
  • Attestations from the provider about counseling on positional therapy and on alcohol and sedatives before bedtime, and from the prescriber that there is no planned surgery for sleep apnea or obesity and no diagnosis of predominant central or mixed sleep apnea.
  • A prescriber who is, or consults with, "A sleep medicine specialist, pulmonologist or otolaryngologist" or "A physician experienced in the evaluation and management of obstructive sleep apnea".

The last point changed recently. The policy's change log for 6/2026 says it "Updated prescriber requirement to include pulmonologist, otolaryngologist, and physicians experienced in the evaluation and management of obstructive sleep apnea."

This route is about sleep apnea. It does not describe coverage of Zepbound for weight loss alone. Zepbound and Mounjaro contain the same ingredient but carry separate labels with different approved uses; see how the Zepbound and Mounjaro labels differ.

Why do some states have different rules?

UnitedHealthcare's weight loss program says so in its own background section: "It is also designed to meet regulatory requirements for coverage of weight loss medications in California, New Mexico, North Dakota Essential Health Benefits (EHB) and New York."

The document gives North Dakota Fully Insured EHB (Small Group and Individual) plans a section of their own, described above. Its general footnote adds: "State mandates may apply."

This page does not interpret those state requirements. If your plan is issued in one of those states, ask UnitedHealthcare which section of the program applies to your plan.

How long does a UnitedHealthcare approval last, and what does renewal require?

The two documents set the periods themselves. This page quotes them with their dates and does not shorten or extend them.

SituationWhat the document saysSource and date
First approval under the weight loss program, general criteriathe line naming Zepbound ends "Authorization will be issued for 6 months."P 1114-22, effective 9/1/2026; read September 29, 2026
First approval, North Dakota Fully Insured EHB section"Zepbound: Authorization will be issued for 6 months."P 1114-22, effective 9/1/2026; read September 29, 2026
Renewal under the weight loss programrenewal authorization for Zepbound "will be issued for 12 months"P 1114-22, effective 9/1/2026; read September 29, 2026
First approval under the sleep apnea policy"Authorization will be issued for 6 months."P 1475-3, effective 9/1/2026; read September 29, 2026
Renewal under the sleep apnea policythe length depends on how long treatment has continued, as the policy sets outP 1475-3, effective 9/1/2026; read September 29, 2026

For the weight loss program, renewal requires documented response since the start of treatment, measured as the policy defines it, together with "Continuation of lifestyle modification". The exact threshold is in the document named below.

For the sleep apnea policy, the renewal criteria differ for patients on and off PAP therapy. They require a documented response measured as the policy defines it, the same diet and activity condition as the first approval, no diagnosis of diabetes, and that the "Patient continues to require treatment for obstructive sleep apnea". The exact thresholds are in the policy.

How can you check your own UnitedHealthcare plan?

The two documents describe programs. Only your plan record says which one applies to you. These questions help:

  1. Does my plan cover weight loss medications? If your coverage comes through an employer, the benefits office can answer this. UnitedHealthcare member services can answer from the plan record.
  2. Is Zepbound on my plan's formulary? Ask for the drug list that applies to your plan, and note the date you checked.
  3. Which prior authorization program applies? Ask whether a request would be reviewed under P 1114-22, under P 1475-3, or under another policy.
  4. Does a state section apply? If your plan is issued in California, New Mexico, North Dakota or New York, ask which part of the program applies.
  5. What will the review ask for? Share the program number with your prescriber. Both documents list the medical records the review asks for.

Medicare questions, including Medicare Advantage plans, are covered separately in the guide on whether Medicare covers Wegovy, Ozempic and other GLP-1 medications. The two documents on this page sit in the commercial section of UnitedHealthcare's provider website.

Whether any medicine is appropriate for you is a separate question from coverage. Medication is prescribed only if a licensed physician determines it is appropriate.

What the primary sources say

  • UnitedHealthcare Pharmacy, Clinical Pharmacy Programs, Program Number 2026 P 1114-22, Prior Authorization/Notification, Plans with Weight Loss/Appetite Suppression Medication Coverage, effective 9/1/2026 (accessed September 29, 2026): "This is an optional program that is put in place for clients or businesses that have elected to cover weight loss products with Prior Authorization/Notification."; "It is also designed to meet regulatory requirements for coverage of weight loss medications in California, New Mexico, North Dakota Essential Health Benefits (EHB) and New York."; "Used as an adjunct to lifestyle modification (e.g., dietary or caloric restriction, exercise, behavioral support, community-based program)"; "Zepbound: Authorization will be issued for 6 months."; "State mandates may apply. Any federal regulatory requirements and the member specific benefit plan coverage may also impact coverage criteria."; "Refer to Nonformulary Zepbound criteria for plans that do not cover weight loss medications."
  • UnitedHealthcare Pharmacy, Clinical Pharmacy Programs, Program Number 2026 P 1475-3, Prior Authorization/Non-Formulary, Zepbound (tirzepatide), Obstructive Sleep Apnea Only, effective 9/1/2026 (accessed September 29, 2026): "Medications for the purpose of weight loss are typically a benefit exclusion. The program allows for coverage of Zepbound for obesity with obstructive sleep apnea."; "Patient is 18 years of age or older"; "A sleep medicine specialist, pulmonologist or otolaryngologist"; "Authorization will be issued for 6 months."; "Patient continues to require treatment for obstructive sleep apnea"
  • Eli Lilly and Company via DailyMed, Zepbound (tirzepatide) prescribing information, set id 487cd7e7-434c-4925-99fa-aa80b1cc776b, updated August 28, 2026 (accessed September 29, 2026): "to reduce excess body weight and maintain weight reduction long term in adults with obesity or adults with overweight in the presence of at least one weight-related comorbid condition"; "to treat moderate to severe obstructive sleep apnea (OSA) in adults with obesity"
  • HealthCare.gov Glossary, Formulary and Prior authorization (accessed September 29, 2026): "A list of prescription drugs covered by a prescription drug plan or another insurance plan offering prescription drug benefits. Also called a drug list."; "Approval from a health plan that may be required before you get a service or fill a prescription in order for the service or prescription to be covered by your plan."

Every source is listed with its address below.


This article is for informational purposes only and does not constitute medical advice or a statement of coverage. UnitedHealthcare documents are quoted word for word as published, with the effective dates shown. Pharmacy policies and drug lists change, so check your own plan documents. Medication is prescribed only if a licensed physician determines it is appropriate.

Frequently Asked Questions

Does UnitedHealthcare cover Zepbound for weight loss?

It depends on whether your plan chose to cover weight loss medications. UnitedHealthcare's prior authorization program P 1114-22, effective September 1, 2026, describes itself as "an optional program that is put in place for clients or businesses that have elected to cover weight loss products with Prior Authorization/Notification." On a plan that made that election, a Zepbound request for weight loss is reviewed against the program's criteria. Coverage depends on your specific plan and its formulary.

Does UnitedHealthcare require prior authorization for Zepbound?

Both UnitedHealthcare documents on Zepbound read on September 29, 2026 are prior authorization programs: P 1114-22 for plans with weight loss medication coverage, and P 1475-3, a prior authorization and non-formulary policy limited to obstructive sleep apnea. Ask UnitedHealthcare which one, if either, applies to your plan.

Can UnitedHealthcare cover Zepbound for sleep apnea if my plan excludes weight loss drugs?

UnitedHealthcare's policy P 1475-3, effective September 1, 2026, says: "Medications for the purpose of weight loss are typically a benefit exclusion. The program allows for coverage of Zepbound for obesity with obstructive sleep apnea." Its criteria include age 18 or older, a BMI of 30 kg/m2 or higher, a sleep study, and a prescriber who is or consults with a sleep medicine specialist, pulmonologist, otolaryngologist or another physician experienced in obstructive sleep apnea. Whether it applies depends on your specific plan.

Does UnitedHealthcare cover Wegovy?

The same weight loss program, P 1114-22, lists Wegovy injection among its products for plans that elected weight loss medication coverage, with its own criteria and approval periods. For plans that do not cover weight loss medications, the program refers to separate Nonformulary Wegovy criteria, which this page did not review. Coverage depends on your specific plan and its formulary.

How long does a UnitedHealthcare approval for Zepbound last?

Under the general criteria of the weight loss program P 1114-22, effective September 1, 2026, the line naming Zepbound ends "Authorization will be issued for 6 months." The sleep apnea policy P 1475-3 says the same for a first approval. Renewal periods and renewal criteria are set out in each document.

Why does my UnitedHealthcare plan answer differently from someone else's?

The weight loss program is optional, so it applies only where the employer or plan sponsor elected weight loss medication coverage. Some states also have their own requirements: the program names California, New Mexico, North Dakota Essential Health Benefits plans and New York. Two members of UnitedHealthcare can therefore be on plans with different drug lists and different programs.

Do these UnitedHealthcare documents apply to Medicare Advantage plans?

The two documents on this page are published in the commercial prior authorization section of UnitedHealthcare's provider website. Medicare coverage of GLP-1 medications, including Medicare Advantage plans, is a separate topic with its own rules. Ask UnitedHealthcare which policy applies to your plan.

Sources

This article is based on the following primary sources. Links open the original documents.

  1. 1.UnitedHealthcare Pharmacy, Program Number 2026 P 1114-22, Prior Authorization/Notification, Plans with Weight Loss/Appetite Suppression Medication Coverage (effective 9/1/2026) · UnitedHealthcare · accessed
  2. 2.UnitedHealthcare Pharmacy, Program Number 2026 P 1475-3, Prior Authorization/Non-Formulary, Zepbound (tirzepatide), Obstructive Sleep Apnea Only (effective 9/1/2026) · UnitedHealthcare · accessed
  3. 3.Zepbound (tirzepatide) prescribing information, DailyMed set id 487cd7e7-434c-4925-99fa-aa80b1cc776b (updated August 28, 2026) · Eli Lilly and Company via DailyMed, U.S. National Library of Medicine · accessed
  4. 4.HealthCare.gov Glossary: Formulary · HealthCare.gov, U.S. Centers for Medicare & Medicaid Services · accessed
  5. 5.HealthCare.gov Glossary: Prior authorization · HealthCare.gov, U.S. Centers for Medicare & Medicaid Services · accessed

Telehealth prescribing rules differ by state. Read the state-by-state guide.

Reviewed by Majesta team

Majesta Health Editorial Team

Clinical Editorial Team

Majesta Health articles are written against primary sources (FDA labeling, NIH and CDC publications, state statutes) and each one passes a documented compliance review before publication. Where an article cites external sources, they are listed at the end of that article so you can check them yourself. No article currently carries an individual physician review; when a physician reviews an article, that page will show the reviewer's name, NPI and review date.

How this article was prepared
  • Written against primary sources: FDA labeling and safety communications, NIH and CDC publications, state statutes and medical board rules
  • Documented compliance review against FDA, FTC and LegitScript requirements before publication
  • External sources, where an article cites them, are listed at the end of that article with links to the original documents
  • Compounded medications are described as not FDA-approved as final products on every page that mentions them
Have a question for our medical team? See our full clinical team page or contact support.